Post-approval studies (Phase 4)Study completedNCT01630200
What this trial is testing
Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Chronic Obstructive Pulmonary Disease and Allied Conditions
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology 80